Anti-tumor activity of lipophilic imidazolium salts on select NSCLC cell lines

Med Chem Res. 2015 Jul;24(7):2838-2861. doi: 10.1007/s00044-015-1330-z. Epub 2015 Feb 13.

Abstract

The anti-tumor activity of imidazolium salts is highly dependent upon the substituents on the nitrogen atoms of the imidazolium cation. We have synthesized and characterized a series of naphthalene-substituted imidazolium salts and tested them against a variety of non-smallcell lung cancer cell lines. Several of these complexes displayed anticancer activity comparable to cisplatin. These compounds induced apoptosis in the NCI-H460 cell line as determined by Annexin V staining, caspase-3, and PARP cleavage. These results strongly suggest that this class of compounds can serve as potent chemotherapeutic agents.

Keywords: Anti-tumor; Anticancer; Apoptosis; Imidazolium cation; Imidazolium salt.